Compare PRAX & ARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | ARW |
|---|---|---|
| Founded | 2015 | 1935 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.4B |
| IPO Year | 2020 | 1994 |
| Metric | PRAX | ARW |
|---|---|---|
| Price | $345.30 | $214.73 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 3 |
| Target Price | ★ $572.13 | $136.00 |
| AVG Volume (30 Days) | 311.4K | ★ 469.7K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 49.93 |
| EPS | N/A | ★ 9.81 |
| Revenue | N/A | ★ $30,852,935,000.00 |
| Revenue This Year | N/A | $13.55 |
| Revenue Next Year | $7,758.26 | $4.58 |
| P/E Ratio | ★ N/A | $22.16 |
| Revenue Growth | N/A | ★ 10.49 |
| 52 Week Low | $37.25 | $101.79 |
| 52 Week High | $392.70 | $237.33 |
| Indicator | PRAX | ARW |
|---|---|---|
| Relative Strength Index (RSI) | 47.08 | 55.22 |
| Support Level | $285.26 | $200.39 |
| Resistance Level | $356.02 | $219.22 |
| Average True Range (ATR) | 17.13 | 5.78 |
| MACD | -4.00 | 1.23 |
| Stochastic Oscillator | 21.92 | 85.47 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the global components business and the global enterprise computing solutions.